Komori
Fuso Pharmaceutical Industries (4538) · FactUpdated the change in title to Head of the Corporate Planning Department

Changes to the Positions of Head of the Production Division and Plant Manager

First written in FY2020-Q1. 1 of 4 entries say "Restated". Latest entry: FY2023-Q3.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2020-Q1 – FY2023-Q32019: 120192020: 120202021: 120212022: 020222023: 1
Same theme, other companies
Change in Directors' Duties and PositionsA theme 84 companies write about · 0 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 4 of 24 companies on the "Worse" side.

30 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 84 companies compared. The sentences above are computed from all 84.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3Updated the change in title to Head of the Corporate Planning DepartmentAnnual report

    「New title Former title Name Effective date Director Head of Corporate Planning Department Director Head of Corporate Planning Office and Head of Business Development and International Business Promotion Office Toda Mikihiro (戸田 幹洋) 1 April 2023」

    The disclosure states that, effective 1 April 2023, Director Toda Mikihiro (戸田 幹洋)'s title will change from Head of Corporate Planning Office and Head of Business Development and International Business Promotion Office to Head of Corporate Planning Department.
  2. FY2021Updated the titles of executives responsible for production, sales and research and developmentAnnual report

    「June 2021 Head of Production Division and Head of Production Control Office (current)」

    The titles effective June 2021 include Head of Production Division and Head of Production Control Office, Head of Sales Division, and responsibility for the Research and Development Center.
  3. FY2020-Q3RestatedAnnual report

    「New title Former title Name Effective date Director Head of Production Division Director Head of Production Division and Head of Joto Plant Chikita Takahiko (千北 隆彦) 1 July 2019 Director Head of Joto Plant, Production Division, and Head of Production Control Office Director Head of Ibaraki Plant, Production Division Oka Junichi (岡 純一) 1 July 2019」

    The changes in titles related to the Head of Production Division and Plant Managers effective 1 July 2019 are being reconfirmed.
  4. FY2020-Q1First statedAnnual report

    「New title Former title Name Effective date Director Head of Production Division Director Head of Production Division and Head of Joto Plant Chikita Takahiko (千北 隆彦) 1 July 2019 Director Head of Joto Plant, Production Division, and Head of Production Control Office Director Head of Ibaraki Plant, Production Division Oka Junichi (岡 純一) 1 July 2019」

    The disclosure states that changes in the titles of directors responsible for the Production Division and plants were resolved effective 1 July 2019.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuso Pharmaceutical Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.